About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Conference & CLE Calendar | Main | BIO Files Amicus Brief in Therasense Case »

August 08, 2010



As other briefs besides BIO's have said, there is essentially no unformity, much less fairness, in how the standard for inequitable conduct is applied by the courts and especially what the correct standard is in the eyes of the Federal Circuit. As much as several Federal Circuit judges have lamented this "plague," those laments, with all due respect, sound hypocritical with the reality of how the Federal Circuit has applied and especially failed to enunciate a consistent, logical, and rational standard for what is inequitable conduct. The fact remains that Federal Circuit's "fuzzy" approach to this question has created this jurisprudential mess, and only they can rectify that mess. We can only hope that the en banc ruling in Therasense will do that, once and for all time.

The comments to this entry are closed.

April 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30